The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas

Laurencet F, Zulian G, Plancherel C, Luthi J, Fey M, Cerny T, Hess U, Rufener B, Ballabeni P, Swiss Group for Clinical Research (SAKK). The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas. Acta haematologica 2007; 117:40-7.